IGXT Stock - IntelGenx Technologies Corp.
Unlock GoAI Insights for IGXT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $1.04M | $950,000 | $1.53M | $1.54M | $742,000 |
| Gross Profit | $-694,000 | $-908,000 | $-721,000 | $67,000 | $742,000 |
| Gross Margin | -66.8% | -95.6% | -47.0% | 4.3% | 100.0% |
| Operating Income | $-9,491,000 | $-9,413,000 | $-7,982,000 | $-6,264,000 | $-9,550,000 |
| Net Income | $-9,927,000 | $-11,967,000 | $-9,312,000 | $-8,246,000 | $-11,867,000 |
| Net Margin | -955.4% | -1259.7% | -606.6% | -534.1% | -1599.3% |
| EPS | $-0.06 | $-0.07 | $-0.07 | $-0.08 | $-0.13 |
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.
Visit WebsiteEarnings History & Surprises
IGXTEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | May 13, 2025 | — | — | — | — |
Q1 2025 | Mar 19, 2025 | — | — | — | — |
Q4 2024 | Nov 7, 2024 | — | — | — | — |
Q3 2024 | Aug 12, 2024 | — | — | — | — |
Q2 2024 | May 15, 2024 | — | $-0.02 | — | — |
Q1 2024 | Mar 21, 2024 | — | $-0.02 | — | — |
Q4 2023 | Nov 9, 2023 | — | $-0.01 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.02 | — | — |
Q2 2023 | May 11, 2023 | — | $-0.02 | — | — |
Q1 2023 | Mar 29, 2023 | — | $-0.02 | — | — |
Q4 2022 | Nov 10, 2022 | $-0.02 | $-0.02 | 0.0% | = MET |
Q3 2022 | Aug 11, 2022 | $-0.02 | $-0.02 | 0.0% | = MET |
Q2 2022 | May 12, 2022 | $-0.02 | $-0.02 | 0.0% | = MET |
Q1 2022 | Mar 24, 2022 | — | $-0.02 | — | — |
Q4 2021 | Nov 11, 2021 | — | $-0.01 | — | — |
Q3 2021 | Aug 4, 2021 | — | $-0.02 | — | — |
Q2 2021 | May 13, 2021 | — | $-0.02 | — | — |
Q1 2021 | Mar 25, 2021 | — | $-0.02 | — | — |
Q4 2020 | Nov 12, 2020 | — | $-0.01 | — | — |
Q3 2020 | Aug 13, 2020 | — | $-0.16 | — | — |
Latest News
Frequently Asked Questions about IGXT
What is IGXT's current stock price?
What is the analyst price target for IGXT?
What sector is IntelGenx Technologies Corp. in?
What is IGXT's market cap?
Does IGXT pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to IGXT for comparison